Endovascular stenting is projected to lead procedure with 69.0% share in 2026, followed by nitinol as anticipated to secure 63.0% share of material in 2026. Adoption reflects anatomical suitability and accepted clinical evidence, with antiplatelet exposure and operator dependence limiting wider use.
Intracranial Stents Total Addressable Market Analysis By End UserIntracranial Stents Total Addressable Market Analysis By MaterialIntracranial Stents Total Addressable Market Analysis By ProcedureIntracranial Stents Total Addressable Market Analysis By ProductIntracranial Stents Total Addressable Market Opportunity Matrix Growth Vs ValueIntracranial Stents Total Addressable Market Breakdown By Product, Application, And Region